Get SOCRA CCRP Exam Practice Questions - Real and Updated

Answer : D

The protocol must provide scientific rationale, including prior nonclinical findings that justify human research.

ICH E6(R2) 6.2.2: ''The protocol should include... a summary of findings from nonclinical studies that potentially have clinical significance and from clinical trials that are relevant to the trial.''

Other listed options belong elsewhere:

IRB approvals (A) are separate administrative records.

SOPs for data collection (B) are sponsor-level procedural documents.

Investigator selection (C) is a sponsor's responsibility, not protocol content.

Thus, the correct answer is D (Summary of nonclinical findings with clinical relevance).

ICH E6(R2), 6.2.2 (Protocol contents).

Answer : A

An Investigational Device Exemption (IDE) allows an unapproved medical device to be used in a clinical investigation.

21 CFR 812.1(a): ''An approved IDE permits a device to be shipped lawfully for the purpose of conducting investigations of the device without complying with other requirements of the Food, Drug, and Cosmetic Act that would otherwise apply.''

It does not allow commercial sale (B), non-study clinical use (C), or marketing as a humanitarian device (D).

Thus, the correct answer is A (Shipped lawfully for clinical study).

21 CFR 812.1(a) (IDE exemption provisions).

Answer : A

When a trial ends at a site, the investigator has an obligation to submit a final report to the IRB/IEC. This is outlined in both ICH and CFR:

ICH E6(R2) 4.13: ''Upon completion of the trial, the investigator should provide the IRB/IEC with a summary of the trial's outcome.''

21 CFR 312.66: Requires investigators to ''report to the IRB all changes in the research activity and all unanticipated problems involving risk, and to provide reports at the end of the study.''

The final report provides closure and documentation that the study was conducted ethically and in compliance with regulatory standards. Other documents listed in the options (monitoring reports, DSMB summaries, subject logs) may be retained by the sponsor or site, but they are not mandated for IRB submission.

Thus, the correct answer is A (Final Report). This ensures the IRB/IEC has an accurate record of study completion, outcome, and compliance with ethical oversight.

ICH E6(R2), 4.13 (Final reporting to IRB/IEC).

21 CFR 312.66 (IRB review and reporting).

Answer : A

Children who are wards of the state receive additional protections in clinical research.

45 CFR 46.409(b): For research involving wards, ''the IRB shall require appointment of an advocate for each child, in addition to any guardian or other advocate who would ordinarily be provided.''

The advocate must have background and experience to act in the child's best interest and cannot be associated with the research.

Thus, an IRB-appointed advocate is mandatory to ensure independent representation of the ward's rights.

Answer : C

Minimal risk determination is a regulatory function of the IRB/IEC.

45 CFR 46.102(j): Defines minimal risk as harm or discomfort not greater than those ordinarily encountered in daily life.

45 CFR 46.109(a): The IRB has authority to approve, require modifications, or disapprove research, including assessment of risk level.

Investigators may propose a study as minimal risk, but only the IRB/IEC can formally classify it.

This ensures independent, unbiased evaluation of risk, protecting participants from investigator or sponsor bias.